ALB and metastatic colorectal cancer: Celgene corporation, the manufacturer of Abraxane®, has developed several albumin-bound therapeutics, with albumin-bound rapamycin (ABI-009) under current investigation in combination with Bevacizumab and mFOLFOX6 in patients with advanced or metastatic colorectal cancer (ClinicalTrials.gov Identifier: NCT03439462).